Related references
Note: Only part of the references are listed.The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C
Hae Won Jung et al.
MEDICINE (2023)
Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study
Behnam Tajik et al.
LIPIDS (2022)
Clinical Importance of the LDL-C/Apolipoprotein B Ratio for Neointimal Formation after Everolimus-Eluting Stent Implantations
Naotaka Akutsu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2022)
Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels
Harold Superko et al.
BIOMEDICINES (2022)
The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
Gunther Silbernagel et al.
BIOMEDICINES (2022)
Remnant cholesterol is associated with cardiovascular mortality
Kerui Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker
Jyoti Aggarwal et al.
INDIAN HEART JOURNAL (2021)
Low-density lipoprotein cholesterol/apolipoprotein B ratio is superior to apolipoprotein B alone in the diagnosis of coronary artery calcification
Tsui-Yen Chang et al.
CORONARY ARTERY DISEASE (2021)
LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study
Soghra Rabizadeh et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
Hiroaki Ikezaki et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Low-density lipoprotein cholesterol-to- apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes
Alena Viktorinova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
Juan Huang et al.
DISEASE MARKERS (2021)
The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease
Heinz Drexel et al.
ATHEROSCLEROSIS (2021)
Small dense low-density lipoprotein: Analytical review
Christina Kanonidou
CLINICA CHIMICA ACTA (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
Jing-Lu Jin et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort study
Eric Y. F. Wan et al.
DIABETES OBESITY & METABOLISM (2020)
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
Edward K. Duran et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Causes and Consequences of Hypertriglyceridemia
Chris J. Packard et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Estimation of the LDL subclasses in ischemic stroke as a risk factor in a Chinese population
Ruisheng Duan et al.
BMC NEUROLOGY (2020)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder
Shihua Sun et al.
JAMA PSYCHIATRY (2019)
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
Erin D. Michos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease
Koshiro Sakai et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)
LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature
Uffe Ravnskov et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile
Anastasiya M. Kaneva et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2017)
Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
Ekaterina A. Ivanova et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study
Shigemasa Tani et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures
Audrey Y. Chu et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators-A pilot
Marek Kucera et al.
CLINICAL BIOCHEMISTRY (2015)
Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures
Audrey Y. Chu et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality Insight From the National Health and Nutrition Examination Survey III (NHANES-III)
Bethany Doran et al.
CIRCULATION (2014)
The composition and metabolism of large and small LDL
Margaret R. Diffenderfer et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
Non-HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study
Brigitte M. Sondermeijer et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Small Dense Low-Density Lipoproteins Cholesterol can Predict Incident Cardiovascular Disease in an Urban Japanese Cohort: The Suita Study
Hidenori Arai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2013)
Adult Current Smoking: Differences in Definitions and Prevalence Estimates-NHIS and NSDUH, 2008
Heather Ryan et al.
JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH (2012)
Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Non-High-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial)
Scott M. Grundy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
Low-density lipoprotein cholesterol to apolipoprotein B ratio is independently associated with metabolic syndrome in Korean men
Chang Hee Kwon et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: Population-based cohort study
Altan Onat et al.
CLINICAL BIOCHEMISTRY (2010)
Lipid levels-in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines
Amit Sachdeva et al.
AMERICAN HEART JOURNAL (2009)
Is It LDL Particle Size or Number that Correlates with Risk for Cardiovascular Disease?
H. Robert Superko et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
Measurement of small dense low-density lipoprotein particles
T Hirano et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2005)
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men -: 13-year follow-up data from the Quebec Cardiovascular Study
AC St-Pierre et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin
CR Sirtori et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2005)
Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load
MY Tsai et al.
CLINICAL CHEMISTRY (2004)
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women
GJ Blake et al.
CIRCULATION (2002)
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis et al.
JOURNAL OF LIPID RESEARCH (2002)
LDL and HDL enriched in triglyceride promote abnormal cholesterol transport
JW Skeggs et al.
JOURNAL OF LIPID RESEARCH (2002)
Share Paper
